
Almirall to initiate three clinical trials in dermatology field
Global pharmaceutical company Almirall has announced it will launch three clinical trials in 2026 to further advances in the medical dermatology field. Speaking at the 44th J.P. Morgan Healthcare Conference, which took place in San Francisco, Almirall CEO Carlos Gallardo said the company was focused on developing impactful novel… Read More

